Home
Reels
Gruplar
Sayfalar
Daha fazla gör
Gruplar Sayfalar Events Blogs Offers Jobs Courses Movies Merits
Giriş yapın Başvur
Theme Switcher
Night Mode
Sponsorluk
Roche’s HER2-Positive Breast Cancer Therapies: Expanding Leadership in Treatment
Expansion into the Adjuvant Setting Roche has reinforced its position in the HER2-positive breast cancer treatment market by entering the adjuvant therapy space. Approvals for PERJETA and HERCEPTIN in early-stage HER2-positive breast cancer have strengthened the company’s portfolio, offering improved patient outcomes. Combining PERJETA and HERCEPTIN with chemotherapy has become a key...
0 Yorumlar ·0 hisse senetleri ·66 Views ·0 önizleme
Please log in to like, share and comment!
Sponsorluk
Upgrade to Pro
Choose the Plan That's Right for You
Upgrade
Sponsorluk
Sponsorluk